Polypills Proven to Reduce Risk of Heart Attacks and Strokes, Now Added to WHO Essential Medicines List
St. Louis, Missouri – Utilizing a single pill that combines medications targeting cardiovascular disease-related conditions has long been recognized for its ability to reduce the risk of death from heart attacks and strokes. The concept of “polypills” for preventing and treating atherosclerotic cardiovascular disease was introduced nearly 25 years ago. Despite the support from a seminal modeling study advocating for their use to reduce cardiovascular disease on a population level, the adoption of polypills worldwide …